Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus
Rev. Assoc. Med. Bras. (1992, Impr.)
;
67(supl.1): 18-21, 2021.
Article
Dans Anglais
| LILACS
| ID: biblio-1287838
ABSTRACT
SUMMARY COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important anti-inflammatory role in preventing severe forms of COVID -19 in patients with DM2.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Diabète de type 2
/
COVID-19
/
Hyperglycémie
Type d'étude:
Facteurs de risque
langue:
Anglais
Texte intégral:
Rev. Assoc. Med. Bras. (1992, Impr.)
Thème du journal:
EducaÆo em Sa£de
/
GestÆo do Conhecimento para a Pesquisa em Sa£de
/
Médicament
Année:
2021
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Universidade Federal de Minas Gerais/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS